Toxins as tools

The Comprehensive Sourcebook of Bacterial Protein Toxins

Volumn , Issue , 2006, Pages 976-990

  Aktories, Klaus ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 70449333878     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012088445-2/50064-0     Document Type: Chapter

References (94)

1. Ahnert-Hilger G., Pahner I., Höltje M. Pore-forming toxins as cell-biological and pharmacological tools. Handbook of Experimental Pharmacology 2000, 557-575. K. Aktories, I. Just (Eds.).
2. Alberts A.S., Treisman R. Activation of RhoA and SAPK/JNK signaling pathways by the RhoA-specific exchange factor mNET1. EMBO J. 1998, 17:4075-4085.
3. Aronson A.I., Shai Y. Why Bacillus thuringiensis insecticidal toxins are so effective: unique features of their mode of action. FEMS Microbiol. Lett. 2001, 195:1-8.
4. Arora N., Williamson L.C., Leppla S.H., Halpern J.L. Cytotoxic effects of a chimeric protein consisting of tetanus toxin light chain and anthrax toxin lethal factor in non-neuronal cells. J. Biol. Chem. 1994, 269:26165-26171.
5. Aullo P., Giry M., Olsnes S., Popoff M.R., Kocks C., Boquet P. A chimeric toxin to study the role of the 21 kDa GTP binding protein Rho in the control of actin microfilament assembly. EMBO J. 1993, 12:921-931.
6. Bagetta G., Nistico G. Tetanus toxin as a neurobiological tool to study mechanisms of neuronal cell death in the mammalian brain. Pharmacol. Ther. 1994, 62:29-39.
7. Bagetta G., Nistico G., Bowery N.G. Characteristics of tetanus toxin and its exploitation in neurodegenerative studies. Trends Pharmacol. Sci. 1991, 12:285-289.
8. Ballard J.D., Collier R.J., Starnbach M.N. Anthrax toxinmediated delivery of a cytotoxic T cell epitope in vivo. Proc. Natl. Acad. Sci. USA 1996, 93:12531-12534.
9. Barth H., Aktories K., Popoff M.R., Stiles B.G. Binary bacterial toxins: biochemistry, biology, and applications of common Clostridium and Bacillus proteins. Microbiol. Mol. Biol. Rev. 2004, 68:373-402.
10. Barth H., Blöcker D., Behlke J., Bergsma-Schutter W., Brisson A., Benz R., Aktories K. Cellular uptake of Clostridium botulinum C2 toxin requires oligomerization and acidification. J. Biol. Chem. 2000, 275:18704-18711.
11. Barth H., Hofmann F., Olenik C., Just I., Aktories K. The N-terminal part of the enzyme component (C2I) of the binary Clostridium botulinum C2 toxin interacts with the binding component C2II and functions as a carrier system for a Rho ADP-ribosylating C3-like fusion toxin. Infect. Immun. 1998, 66:1364-1369.
12. Barth H., Olenik C., Sehr P., Schmidt G., Aktories K., Meyer D.K. Neosynthesis and activation of Rho by Escherichia coli cytotoxic necrotizing factor (CNF1) reverse cytopathic effects of ADP-ribosylated Rho. J. Biol. Chem. 1999, 274:27407-27414.
13. Bhakdi S., Valeva A., Walev I., Weller U., Palmer M. Pore-forming toxins. Bacterial Toxins-Tools in Cell Biology and Pharmacology 1997, 241-257. Chapman & Hall, Weinheim. K. Aktories (Ed.).
14. Bishop A.L., Hall A. Rho GTPases and their effector proteins. Biochem. J. 2000, 348:241-255.
15. Blitzer A., Binder W.J. Cosmetic uses of botulinum neurotoxin type A: an overview. Arch. Facial. Plast. Surg. 2002, 4:214-220.
16. Cassel D., Pfeuffer T. Mechanism of cholera toxin action: Covalent modification of the guanyl nucleotide-binding protein of the adenylate cyclase system. Proc. Natl. Acad. Sci. USA 1978, 75:2669-2673.
17. Chaves-Olarte E., Guzman-Verri C., Meresse S., Desjardins M., Pizarro-Cerda J., Badilla J., Gorvel J.P., Moreno E. Activation of Rho and Rab GTPases dissociates Brucella abortus internalization from intracellular trafficking. Cell Microbiol. 2002, 4:663-676.
18. 2 toxin and steroid production in adrenal Y-1 cells: The role of microfilaments in the toxin-induced increase in steroid release. J. Pharmacol. Exp. Ther. 1992, 260:859-864.
19. Cooper J.A. Effects of cytochalasin and phalloidin on actin. J. Cell Biol. 1987, 105:1473-1478.
20. Doye A., Mettouchi A., Bossis G., Clément R., Buisson-Touati C., Flatau G., Gagnoux L., Piechaczyk M., Boquet P., Lemichez E. CNF1 exploits the ubiquitin-proteasome machinery to restrict Rho GTPase activation for bacterial host cell invasion. Cell 2002, 111:553-564.
21. Eckhardt M., Barth H., Blöcker D., Aktories K. Binding of Clostridium botulinum C2 toxin to asparagine-linked complex and hybrid carbohydrates. J. Biol. Chem. 2000, 275:2328-2334.
22. Fiorentini C., Gauthier M., Donelli G., Boquet P. Bacterial toxins and the Rho GTP-binding protein: what microbes teach us about cell regulation. Cell Death & Differentiation 1998, 5:720-728.
23. Flatau G., Lemichez E., Gauthier M., Chardin P., Paris S., Fiorentini C., Boquet P. Toxin-induced activation of the G protein p21 Rho by deamidation of glutamine. Nature 1997, 387:729-733.
24. Gasman S., Chasserot-Golaz S., Popoff M., Aunis D., Bader M.F. Involvement of Rho GTPases in calciumregulated exocytosis from adrenal chromaffin cells. J. Cell Sci. 1999, 112:4763-4771.
25. Genth H., Gerhard R., Maeda A., Amano M., Kaibuchi K., Aktories K., Just I. Entrapment of Rho ADP-ribosylated by Clostridium botulinum C3 exoenzyme in the Rho-GDI-1 complex. J. Biol. Chem. 2003, in press.
26. Gierschik P., Sidiropoulos D., Jakobs K.H. Two distinct Gi-proteins mediate formyl peptide receptor signal transduction in human leukemia (HL-60) cells. J. Biol. Chem. 1989, 264:21470-21473.
27. Gill D.M. Mechanism of action of cholera toxin. Adv. Cyclic Nucleotide Res. 1977, 8:85-118.
28. Hayakawa T., Takanaga A., Tanaka K., Maeda S., Seki M. Distribution and ultrastructure of dopaminergic neurons in the dorsal motor nucleus of the vagus projecting to the stomach of the rat. Brain Res. 2004, 1006:66-73.
29. Heckmann M., Ceballos-Baumann A.O., Plewig G. Botulinum toxin A for axillary hyperhidrosis (excessive sweating). N. Engl. J. Med. 2001, 344:488-493.
30. Henning S.W., Galandrini R., Hall A., Cantrell D.A. The GTPase Rho has a critical regulatory role in thymus development. EMBO J. 1997, 16:2397-2407.
31. Hilal-Dandan R., Means C.K., Gustafsson A.B., Morissette M.R., Adams J.W., Brunton L.L., Heller B.J. Lysophosphatidic acid induces hypertrophy of neonatal cardiac myocytes via activation of Gi and Rho. J. Mol. Cell Cardiol. 2004, 36:481-493.
32. Holzinger A. Jasplakinolide. An actin-specific reagent that promotes actin polymerization. Methods Mol. Biol. 2001, 161:109-120.
33. Hopkins A.M., Walsh S.V., Verkade P., Boquet P., Nusrat A. Constitutive activation of Rho proteins by CNF-1 influences tight junction structure and epithelial barrier function. J. Cell Sci. 2003, 116:725-742.
34. Just I., Gerhard R. Large clostridial cytotoxins. Rev. Physiol Biochem. Pharmacol. 2004, 152:23-47.
35. Just I., Selzer J., Wilm M., Von Eichel-Streiber C., Mann M., Aktories K. Glucosylation of Rho proteins by Clostridium difficile toxin B. Nature 1995, 375:500-503.
36. Kaper J.B., Morris J.G., Levine M.M. Cholera. Clin. Microbiol. Rev. 1995, 8:48-86.
37. Kishi K., Sasaki T., Kuroda S., Itoh T., Takai Y. Regulation of cytoplasmic division of Xenopus embryo by rho p21 and its inhibitory GDP/GTP exchange protein (rho GDI). J. Cell Biol. 1993, 120:1187-1195.
38. Klussmann E., Tamma G., Lorenz D., Wiesner B., Maric K., Hofmann F., Aktories K., Valenti G., Rosenthal W. An inhibitory role of Rho in the vasopressin-mediated translocation of aquaporin-2 into cell membranes of renal principal cells. J. Biol. Chem. 2001, 276:20451-20457.
39. Kreitman R.J. Immunotoxins in cancer therapy. Curr. Opin. Immunol. 1999, 11:570-578.
40. Lax A.J., Pullinger G.D., Baldwin M.R., Harmey D., Grigoriadis A.E., Lakey J.H. The pasteurella multocida toxin interacts with signaling pathways to perturb cell growth and differentiation. Int. J. Med. Microbiol. 2004, 293:505-512.
41. Lehmann M., Fournier A., Selles-Navarro I., Dergham P., Sebock A., Leclerc N., Tigyi G., McKerracher L. Inactivation of Rho signaling pathway promotes CNS axon regeneration. Journal of Neuroscience 1999, 19:7537-7547.
42. Li G., Rungger-Brändle E., Just I., Jonas J.C., Aktories K., Wollheim C.B. Effect of disruption of actin filaments by Clostridium botulinum C2 toxin on insulin secretion in HIT-T15 cells and pancreatic islets. Mol. Biol. Cell 1994, 5:1199-1213.
43. Maddala R., Deng P.F., Costello J.M., Wawrousek E.F., Zigler J.S., Rao V.P. Impaired cytoskeletal organization and membrane integrity in lens fibers of a Rho GTPase functional knockout transgenic mouse. Lab Invest 2004, 84:679-692.
44. Madden J.C., Ruiz N., Caparon M. Cytolysin-mediated translocation (CMT): a functional equivalent type III secretion in Gram-positive bacteria. Cell 2001, 104:143-152.
45. Mao J., Xie W., Yuan H., Simon M.I., Mano H., Wu D. Tec/Bmx non-receptor tyrosine kinases are involved in regulation of Rho and serum response factor by Ga12/13. EMBO J. 1998, 17:5638-5646.
46. Masuda M., Betancourt L., Matsuzawa T., Kashimoto T., Takao T., Shimonishi Y., Horiguchi Y. Activation of Rho through a cross-link with polyamines catalyzed by Bordetella dermonecrotizing toxin. EMBO J. 2000, 19:521-530.
47. Matter K., Dreyer F., Aktories K. Actin involvement in exocytosis from PC12 cells: studies on the influence of botulinum C2 toxin on stimulated noradrenaline release. J. Neurochem. 1989, 52:370-376.
48. Mauss S., Chaponnier C., Just I., Aktories K., Gabbiani G. ADP-ribosylation of actin isoforms by Clostridium botulinum C2 toxin and Clostridium perfringens iota toxin. Eur. J. Biochem. 1990, 194:237-241.
49. Meacci E., Vasta V., Moorman J.P., Bobak D.A., Bruni P., Moss J., Vaughan M. Effect of Rho and ADP-ribosylation factor GTPase on phospholipase D activity in intact human adenocarcinoma A549 cells. J. Biol. Chem. 1999, 274:18605-18612.
50. Mehlig M., Moos M., Braun V., Kalt B., Mahony D.E., Von Eichel-Streiber C. Variant toxin B and a functional toxin A produced by Clostridium difficile C34. FEMS Microbiol. Lett. 2001, 198:171-176.
51. Munchau A., Bhatia K.P. Uses of botulinum toxin injection in medicine today. BMJ 2000, 320:161-165.
52. Murphy A.C., Rozengurt E. Pasteurella multocida toxin selectively facilitates phosphatidylinositol 4,5-bisphosphate hydrolysis by bombesin, vasopressin, and endothelin. Requirement for a functional G protein. J. Biol. Chem. 1992, 267:25296-25303.
53. Nobes C.D., Hall A. Rho, Rac, and Cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia. Cell 1995, 81:53-62.
54. - production and secretion but inhibits migration of activated human neutrophils. J. Clin. Invest. 1988, 82:1376-1382.
55. Nürnberg B. Pertussis toxin as a cell biological tool. Bacterial Toxins-Tools in Cell Biology and Pharmacology 1997, 47-60. Chapman & Hall. K. Aktories (Ed.).
56. Ohishi I., Iwasaki M., Sakaguchi G. Purification and characterization of two components of botulinum C2 toxin. Infect. Immun. 1980, 30:668-673.
57. Palmer M. The family of thiol-activated, cholesterol-binding cytolysins. Toxicon 2001, 39:1681-1689.
58. Park J., Kim J.S., Jung K.C., Lee H.J., Kim J.I., Kim J., Lee J.Y., Park J.B., Choi S.Y. Exoenzyme Tat-C3 inhibits association of zymosan particles, phagocytosis, adhesion, and complement binding in macrophage cells. Mol. Cells 2003, 16:216-223.
59. rho induces rapid changes in cell morphology. J. Cell Biol. 1990, 111:1001-1007.
60. Payling-Wright G. The neurotoxins of Clostridium botulinum and Clostridium tetani. Pharmacol. Rev. 1955, 7:413-465.
61. Plant A., Williams N.A. Modulation of the immune response by the cholera-like enterotoxins. Curr. Top. Med. Chem. 2004, 4:509-519.
62. Popoff M.R., et al. Ras, Rap, and Rac small GTP-binding proteins are targets for Clostridium sordellii lethal toxin glucosylation. J. Biol. Chem. 1996, 271:10217-10224.
63. Porta M. A comparative trial of botulinum toxin type A and methylprednisolone for the treatment of myofascial pain syndrome and pain from chronic muscle spasm. Pain 2000, 85:101-105.
64. Prepens U., Barth H., Wilting J., Aktories K. Influence of Clostridium botulinum C2 toxin on FceRI-mediated secretion and tyrosine phosphorylation in RBL cells. Naunyn-Schmiedeberg's Arch. Pharmacol. 1998, 357:323-330.
65. Prepens U., Just I., Von Eichel-Streiber C., Aktories K. Inhibition of FceRI-mediated activation of rat basophilic leukemia cells by Clostridium difficile toxin B (monoglucosyltransferase). J. Biol. Chem. 1996, 271:7324-7329.
66. Rao V., Wawrousek E., Tamm E.R., Zigler S Rho GTPase inactivation impairs lens growth and integrity. Lab Invest. 2002, 82:231-239.
67. Ridley A.J., Hall A. The small GTP-binding protein Rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors. Cell 1992, 70:389-399.
68. Rossetto O., Seveso M., Caccin P., Schiavo G., Montecucco C. Tetanus and botulinum neurotoxins: turning bad guys into good by research. Toxicon 2001, 39:27-41.
69. Sadoul K., Lang J., Montecucco C., Weller U., Regazzi R., Catsicas S., Wollheim C.B., Halban P.A. SNAP-25 is expressed in islets of Langerhans and is involved in insulin release. J. Cell Biol. 1995, 128:1019-1028.
70. Sauzeau V., Le Mellionnec E., Bertoglio J., Scalbert E., Pacaud P., Loirand G. Human urotensin II-induced contraction and arterial smooth muscle cell proliferation are mediated by RhoA and Rho-kinase. Circ. Res. 2001, 88:1102-1104.
71. Schiavo G., Matteoli M., Montecucco C. Neurotoxins affecting neuroexocytosis. Physiol. Rev. 2000, 80:717-766.
72. Schiavo G., Matteoli M., Montecucco C. Neurotoxins affecting neuroexocytosis. Physiol Rev. 2000, 80:717-766.
73. Schmidt G., Sehr P., Wilm M., Selzer J., Mann M., Aktories K. Gln63 of Rho is deamidated by Escherichia coli cytotoxic necrotizing factor 1. Nature 1997, 387:725-729.
74. Schnepf E., Crickmore N., van Rie J., Lereclus D., Baum J., Feitelson J., Zeigler D.R., Dean D.H. Bacillus thuringiensis and its pesticidal crystal proteins. Microbiol. Mol. Biol. Rev. 1998, 62:775-806.
75. Sehr P., Joseph G., Genth H., Just I., Pick E., Aktories K. Glucosylation and ADP-ribosylation of Rho proteins-effects on nucleotide binding, GTPase activity, and effector-coupling. Biochemistry 1998, 37:5296-5304.
76. Shupliakov O., Bloom O., Gustafsson J.S., Kjaerulff O., Low P., Tomilin N., Pieribone V.A., Greengard P., Brodin L. Impaired recycling of synaptic vesicles after acute perturbation of the presynaptic actin cytokeleton. Proc. Natl. Acad. Sci. USA 2002, 99:14476-14481.
77. Silberstein S., Mathew N., Saper J., Jenkins S. Botulinum toxin type A as a migraine preventive treatment. For the BOTOX Migraine Clinical Research Group. Headache 2000, 40:445-450.
78. Song L., Hobaugh M.R., Shustak C., Cheley S., Bayley H., Gouaux J.E. Structure of staphylococcal a-hemolysin, a heptameric transmembrane pore. Science 1996, 274:1859-1866.
79. Sotiropoulos A., Gineitis D., Copeland J., Treisman R. Signal-regulated activation of serum response factor is mediated by changes in actin dynamic. Cell 1999, 98:159-169.
80. Spector I., Braet F., Shochet N.R., Bubb M.R. New anti-actin drugs in the study of the organization and function of the actin cytoskeleton. Microscopy Research and Technique 1999, 47:18-37.
81. Valderrama F., Duran J.M., Babia T., Barth H., Renau-Piqueras J., Egea G. Actin microfilaments facilitate the retrograde transport from the Golgi complex to the endoplasmic reticulum in mammalian cells. Traffic 2001, 2:717-726.
82. Van Aelst L., D'Souza-Schorey C. Rho GTPases and signaling networks. Genes & Development 1997, 11:2295-2322.
83. Van den Akker F., Merritt E.A., Hol W.G.J. Structure and function of cholera toxin and related enterotoxins. Bacterial Protein Toxins 2000, 109-131. Springer, Weinheim. K. Aktories, I. Just (Eds.).
84. van der Goot F.G. Pore-forming toxins. Curr. Top. Microbiol. Immunol. 2001, 257:1-166.
85. Wahl S., Barth H., Ciossek T., Aktories K., Mueller B.K. Ephrin-A5 induces collapse of growth cones by activating Rho and Rho kinase. J. Cell Biol. 2000, 149:263-270.
86. Walev I., Bhakdi S.C., Hofmann F., Djouder N., Valeva A., Aktories K., Bhakdi S. Delivery of proteins into living cells by reversible membrane permeabilization with streptolysin-O. Proc. Natl. Acad. Sci. USA 2001, 98:3185-3190.
87. Wegner A., Aktories K. ADP-ribosylated actin caps the barbed ends of actin filaments. J. Biol. Chem. 1988, 263:13739-13742.
88. Wilde C., Barth H., Sehr P., Han L., Schmidt M., Just I., Aktories K. Interaction of the Rho-ADP-ribosylating C3 exoenzyme with RalA. J. Biol. Chem. 2002, 277:14771-14776.
89. Wilde C., Chhatwal G.S., Schmalzing G., Aktories K., Just I. A novel C3-like ADP-ribosyltransferase from Staphylococcus aureus modifying RhoE and Rnd3. J. Biol. Chem. 2001, 276:9537-9542.
90. Wilson B.A., Ho M. Pasteurella multocida toxin as a tool for studying G(q) signal transduction. Rev. Physiol Biochem. Pharmacol. 2004, 152:93-109.
91. qa-coupled phospholipase C-b1. J. Biol. Chem. 1997, 272:1268-1275.
92. Winton M.J., Dubreuil C.I., Lasko D., Leclerc N., McKerracher L. Characterization of new cell permeable C3-like proteins that inactivate Rho and stimulate neurite out-growth on inhibitory substrates. J. Biol. Chem. 2002, 277:32820-32829.
93. Yamaizumi M., Mekada E., Uchida T., Okada Y. One molecule of diphtheria toxin fragment A introduced into a cell can kill the cell. Cell 1978, 15:245-250.
94. Zywietz A., Gohla A., Schmelz M., Schultz G., Offermanns S. Pleiotropic effects of Pasteurella multocida toxin are mediated by Gq-dependent and -independent mechanisms. Involvement of Gq but not G11. J. Biol. Chem. 2001, 276:3840-3845.